UBS Maintains Neutral on Insulet, Lowers Price Target to $150

Insulet Corporation

Insulet Corporation

PODD

0.00

UBS analyst Patrick Wood maintains Insulet (NASDAQ: PODD) with a Neutral and lowers the price target from $174 to $150.